Citation Formats
The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Ünver Et Al. , "The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever," Neuromuscular Disorders , vol.32, no.7, pp.575-577, 2022

Ünver, O. Et Al. 2022. The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever. Neuromuscular Disorders , vol.32, no.7 , 575-577.

Ünver, O., Çelik, T., Memişoğlu, A., Büyükbayrak, E. E., Tülin Şimşek, F., Öztürk, G., ... Eser, G.(2022). The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever. Neuromuscular Disorders , vol.32, no.7, 575-577.

Ünver, Olcay Et Al. "The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever," Neuromuscular Disorders , vol.32, no.7, 575-577, 2022

Ünver, Olcay Et Al. "The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever." Neuromuscular Disorders , vol.32, no.7, pp.575-577, 2022

Ünver, O. Et Al. (2022) . "The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever." Neuromuscular Disorders , vol.32, no.7, pp.575-577.

@article{article, author={Olcay Ünver Et Al. }, title={The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever}, journal={Neuromuscular Disorders}, year=2022, pages={575-577} }